Clinical TrialID 6862
Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM)
NCT02114957
Healthy
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6862
- Evidence Id
- 6862
- Core Evidence Id
- 6862
- Source Clinical Trial Id
- 6853
- Herb2 Clinical Trial Id
- HBCT006853
- Nct Id
- NCT02114957
- Title
- Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM)
- Status
- Completed
- Phase
- Early_Phase 1
- Study Result
- No
- Study Condition
- Healthy
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
- Intervention
- DIETARY_SUPPLEMENT: 800mg dietary supplement CognIQTM (4 capsules) by oral at hour 0
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Basic_Science
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 20
- Outcome Measure
- Area under the plasma concentration versus time curve (AUC) of decursin, decursinol angelate (DA) and decursinol, 0, 0.5, 1, 2, 3, 4, 6, 8, 12 , 24, 48 hours post-dose
- Sponsor Collaborator
- Texas Tech University Health Sciences Center
- Funded By
- OTHER
- Location
- Clinical Research Unit, School of Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106, United States
- Other Id
- A12-3742
- Start Date
- 2013-01
- Primary Completion Date
- 2013-04
- Completion Date
- First Posted
- 2014-04-15
- Results First Posted
- Last Update Posted
- 2014-04-15
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT02114957
- Title Cn
- Title En
- Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM)
- Bilingual Status
- semi_complete